The Eight B Vitamins: Every Form, and Why the Form Matters

The eight B vitamins are thiamine (B1), riboflavin (B2), niacin (B3), pantothenic acid (B5), pyridoxine (B6), biotin (B7), folate (B9) and cobalamin (B12). None of them is a source of energy. Each is a precursor that your body converts into a coenzyme, and those coenzymes run the reactions that turn food into ATP. The form on the label determines how many conversion steps you still have to do.

Do B Vitamins Actually Give You Energy?

No. This is the most important sentence in the article, so it goes first.

B vitamins contain no calories. Energy in a biological sense means ATP, and ATP is made by oxidising carbohydrate, fat and protein. B vitamins are the tools that do the oxidising. A wrench does not contain torque. It transmits it.

The technical word is catalytic. A coenzyme participates in a reaction and comes out the other side unchanged, ready to do it again. One molecule of thiamine pyrophosphate can process an enormous number of pyruvate molecules over its lifetime. That is why the daily requirement for thiamine is 1.1 to 1.2 mg while the daily requirement for glucose runs to hundreds of grams. You need a rounding error of vitamin to process a mountain of fuel. We walk through the full pathway in how your body actually makes energy.

The practical consequence: adding more of a cofactor to a system that already has enough does nothing. Enzymes are saturable. Once every active site has its coenzyme bound, extra coenzyme sits in the cytosol waiting, and eventually leaves in your urine.

This is not a fringe position. Markun and colleagues, writing in Nutrients in 2021, pooled 16 randomized controlled trials covering 6,276 participants — mostly older adults, with and without mild cognitive impairment, none with overt B12 deficiency — and found "no evidence for an effect of B12 alone or B complex supplementation on any subdomain of cognitive function outcomes" and "no overall effect of vitamin supplementation on measures of depression." Only one included study reported on fatigue, which is too few to pool. That is the honest state of the evidence in people who were not deficient.

A 2019 systematic review by Young and colleagues, also in Nutrients, covering 16 trials and 2,015 participants, found a small but statistically significant benefit of B vitamins on stress (standardised mean difference 0.23, 95% CI 0.02–0.45, p = 0.03), no significant effect on depressive symptoms (p = 0.07) and no effect at all on anxiety (p = 0.71). Crucially, the benefits clustered in participants with poor baseline mood or nutritional status. That is the shape of a genuine repletion effect, not a drug effect.

So the honest claim is narrow and it is the one worth making: B vitamins are required for energy metabolism. Being short of them constrains it. Supplying them when you already have enough does not accelerate anything. If you are tired, the reasons are usually sleep, iron, thyroid, and stress — we cover that in why you might always be tired.

What Are the Eight B Vitamins, and What Does Each One Become?

The B vitamins are grouped together for a historical reason, not a chemical one. Early researchers isolated a heat-labile "water-soluble B" fraction from yeast and rice polishings and later discovered it contained several distinct compounds. They are structurally unrelated. B4, B8, B10 and B11 were assigned and then withdrawn when the substances turned out not to be vitamins, which is why the numbering has gaps.

What they share is that each becomes a coenzyme.

Vitamin	Coenzyme form	Adult RDA or AI	Upper limit (US)	Where it acts
B1 Thiamine	Thiamine pyrophosphate (TPP)	1.2 mg men / 1.1 mg women	None set	Pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, transketolase
B2 Riboflavin	FMN and FAD	1.3 mg men / 1.1 mg women	None set	Complex I and II, beta-oxidation, glutathione reductase, MTHFR, B6 activation
B3 Niacin	NAD and NADP	16 mg NE men / 14 mg NE women	35 mg (supplemental, flushing-based)	Every dehydrogenase in glycolysis and the Krebs cycle; NADPH for biosynthesis and antioxidant recycling
B5 Pantothenic acid	Coenzyme A, acyl carrier protein	5 mg (AI)	None set	Acetyl-CoA — the entry point to the Krebs cycle; fatty acid synthesis and breakdown
B6 Pyridoxine	Pyridoxal-5'-phosphate (PLP)	1.3 mg	100 mg (US); 12 mg (EFSA, 2023)	Over 100 enzyme reactions: transamination, glycogen breakdown, haem synthesis, neurotransmitter synthesis
B7 Biotin	Biotin, covalently bound to carboxylases	30 mcg (AI)	None set	Five carboxylases: gluconeogenesis, fatty acid synthesis, amino acid catabolism
B9 Folate	Tetrahydrofolate and its one-carbon derivatives	400 mcg DFE	1,000 mcg (synthetic forms only)	DNA synthesis, the methylation cycle, amino acid interconversion
B12 Cobalamin	Methylcobalamin and adenosylcobalamin	2.4 mcg	None set	Methionine synthase (cytosol) and methylmalonyl-CoA mutase (mitochondria)

Values are from the NIH Office of Dietary Supplements health professional fact sheets. "NE" means niacin equivalents, which accounts for niacin the body makes from tryptophan at a conversion ratio of roughly 60 mg tryptophan to 1 mg niacin. "DFE" means dietary folate equivalents, which we will get to.

Note how few upper limits exist. That is not because these compounds are inert at any dose. It is because the Food and Nutrition Board sets a UL only when there is enough human data to derive one. Absence of a UL is absence of evidence, and the B6 story below shows exactly how that can change.

Why Does the Form of a B Vitamin Matter?

Because a label that says "Vitamin B12, 500 mcg" tells you the dose and hides the chemistry. Almost every B vitamin exists in a cheap, shelf-stable, chemically simple form and in one or more coenzyme forms. The gap between them is a conversion step, and every conversion step has requirements: an enzyme, usually ATP and magnesium, sometimes another B vitamin.

For most people, most of the time, those conversion steps work fine. The forms question matters when the conversion is slow (folic acid), when the conversion consumes something scarce (cyanocobalamin), when the form carries a different safety profile (pyridoxine), or when the form goes somewhere different in the body (benfotiamine).

Vitamin	Cheap or common form	Bioactive or coenzyme form	What the conversion needs	Who should actually care
B1	Thiamine HCl, thiamine mononitrate	Thiamine pyrophosphate (TPP)	Thiamine pyrophosphokinase, which requires ATP and magnesium	Almost nobody, for the salt choice. Mononitrate is more stable in fortified flour; HCl dissolves better in liquids. Benfotiamine is a fat-soluble derivative studied mostly in diabetic neuropathy — a clinical context, not a general one.
B2	Riboflavin	FMN, then FAD (riboflavin-5'-phosphate on labels is FMN)	Riboflavin kinase (ATP, magnesium, zinc), then FAD synthetase	Very few. The conversion is fast and not known to be rate-limiting. R5P is marketed as "activated" but the human evidence for superiority is thin.
B3	Nicotinic acid ("niacin"), niacinamide (nicotinamide)	NAD, NADP	Different routes; both converge on NAD	Anyone who dislikes flushing. Nicotinic acid causes flushing from about 30–50 mg. Niacinamide does not. NR and NMN are separate compounds sold as NAD precursors and are not marketed or labelled as sources of niacin.
B5	Calcium d-pantothenate	Coenzyme A	A five-step pathway starting with pantothenate kinase (ATP, magnesium)	Almost nobody. Pantethine is one step further along and has been studied at gram doses for lipid effects — a different use case at a different dose.
B6	Pyridoxine HCl	Pyridoxal-5'-phosphate (PLP or P5P)	Pyridoxal kinase (ATP, magnesium), then PNPO — which is an FMN-dependent flavoenzyme, so riboflavin is required	This is the one worth knowing about. The safety picture differs between forms in ways regulators are actively examining, and the conversion depends on two other nutrients.
B7	d-Biotin	Biotin, attached to carboxylases by holocarboxylase synthetase	ATP	Only one form is sold. The real issue with biotin is dose, not form — see below.
B9	Folic acid (fully oxidised, synthetic)	5-methyltetrahydrofolate (5-MTHF); folinic acid sits partway	Folic acid requires dihydrofolate reductase (DHFR) — twice — then several more steps including MTHFR, which needs an FAD cofactor from riboflavin	People taking high folic acid doses; anyone interested in unmetabolized folic acid. Note: folic acid remains the only form with randomized evidence behind neural tube defect prevention.
B12	Cyanocobalamin	Methylcobalamin (cytosol), adenosylcobalamin (mitochondria); hydroxocobalamin is the natural circulating form	Removal of the cyanide group and reduction of the cobalt, then methylation or adenosylation — all forms converge here	People with impaired absorption. Also worth knowing: the NIH states plainly that no evidence indicates absorption varies by form.

Two patterns fall out of that table. First, magnesium appears again and again, because most of these activations are ATP-dependent kinase reactions and the substrate of a kinase is Mg-ATP, not ATP. Second, riboflavin gates two other B vitamins — B6 activation and folate cycling — which makes it quietly the most load-bearing of the eight.

Vitamin B1 (Thiamine): TPP, and the Gate on Glucose

RDA: 1.2 mg/day for men, 1.1 mg/day for women. No upper limit; absorption drops off sharply above about 5 mg and the excess leaves in urine.

Coenzyme form: thiamine pyrophosphate. About 80% of the roughly 25–30 mg of thiamine in an adult body is in this form. The Linus Pauling Institute states the conversion requirement directly: "The synthesis of TPP from free thiamin requires magnesium, adenosine triphosphate (ATP), and the enzyme, thiamin pyrophosphokinase."

Where it acts: TPP is a cofactor for five enzymes and the first two are chokepoints. Pyruvate dehydrogenase converts pyruvate to acetyl-CoA — the single step connecting glycolysis to the Krebs cycle. Alpha-ketoglutarate dehydrogenase sits inside the Krebs cycle. Transketolase runs the pentose phosphate pathway, generating NADPH and the ribose for nucleotides. Without TPP, glucose is broken down to pyruvate but cannot enter the mitochondria, so cells with high glucose dependence — neurons, cardiac muscle — fail first.

Deficiency and who is at risk: beriberi, in a "wet" form dominated by heart failure and oedema and a "dry" form dominated by peripheral neuropathy and wasting. In wealthy countries the more common presentation is Wernicke-Korsakoff syndrome; the NIH notes that without treatment up to 20% of people with Wernicke's encephalopathy die. At risk: people with alcohol dependence (up to 80% develop deficiency), older adults (20–30% show laboratory indicators), people after bariatric surgery, people with HIV/AIDS or diabetes, and diuretic users. Food sources: pork, fish, whole grains, legumes, sunflower seeds, fortified cereals.

On the forms: thiamine HCl and mononitrate are both simple salts and both work. Mononitrate is less hygroscopic, which suits flour fortification; HCl dissolves more readily, which suits drink mixes. Benfotiamine is a lipid-soluble derivative producing higher blood thiamine than equivalent water-soluble doses, studied mainly in diabetic neuropathy at doses far above dietary levels, with mixed results. A clinical tool, not a general upgrade.

Vitamin B2 (Riboflavin): FMN, FAD, and the Vitamin That Activates Other Vitamins

RDA: 1.3 mg/day for men, 1.1 mg/day for women. No upper limit; the NIH notes no adverse effects even at 400 mg/day for three months.

Coenzyme forms: flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). Flavoproteins are redox enzymes — they hand electrons back and forth.

Where it acts: FMN is the electron entry point of Complex I of the electron transport chain. FAD is bound inside Complex II (succinate dehydrogenase), simultaneously a Krebs cycle enzyme and a respiratory complex. FAD also runs the acyl-CoA dehydrogenases that begin every round of fat oxidation, and glutathione reductase, which regenerates reduced glutathione — which is why riboflavin turns up in any serious discussion of who actually benefits from antioxidants.

And then the part almost nobody mentions. The NIH states it plainly: "The conversion of vitamin B6 to the coenzyme pyridoxal 5'-phosphate needs FMN." Riboflavin is also the source of the FAD cofactor for MTHFR, the enzyme that makes 5-MTHF. Riboflavin status therefore sits upstream of both B6 activation and folate cycling — being short of it constrains two other B vitamins at once. This is the sort of dependency we map out in nutrient cofactors and synergy.

Deficiency and who is at risk: ariboflavinosis — angular stomatitis (cracks at the corners of the mouth), cheilosis, glossitis, sore throat, itchy red eyes. It rarely occurs alone. At risk: vegans with low dairy intake, vegetarian athletes, pregnant and lactating women eating little meat or dairy, and people with the rare riboflavin transporter deficiency. Food sources: beef liver (2.9 mg per 3 oz), fortified cereals, milk (0.5 mg per cup), yogurt, eggs, mushrooms, almonds.

On the forms: riboflavin-5'-phosphate — which is FMN — is sold as the "activated" form. The kinase step it bypasses is not known to be rate-limiting in healthy people, and there is no good human trial showing an advantage.

Vitamin B3 (Niacin): NAD, NADP, and the Flushing Question

RDA: 16 mg NE/day for men, 14 mg NE/day for women. UL: 35 mg/day, which applies only to supplemental niacin and is based entirely on skin flushing, not on organ toxicity.

Coenzyme forms: NAD and NADP. NAD is the universal electron acceptor of catabolism; NADP (as NADPH) is the universal electron donor of biosynthesis and antioxidant recycling. The NIH describes NADP as enabling "anabolic reactions, such as the synthesis of cholesterol and fatty acids" and playing "a critical role in maintaining cellular antioxidant function."

Where it acts: essentially everywhere. Glyceraldehyde-3-phosphate dehydrogenase in glycolysis. Three separate steps in the Krebs cycle. Complex I accepts electrons directly from NADH. NAD is also the substrate for sirtuins and PARPs, which is why it has become a longevity-research obsession.

Deficiency and who is at risk: pellagra — dermatitis on sun-exposed skin, diarrhoea, dementia, with depression, apathy, headache and memory loss. Rare where corn is nixtamalised or diets are varied. At risk: undernutrition from poverty, alcohol use disorder, AIDS, inflammatory bowel disease or cirrhosis; Hartnup disease; carcinoid syndrome; and — this is the interesting one — people with inadequate riboflavin, B6 or iron, because all three are required to convert tryptophan into niacin. Food sources: beef liver (14.9 mg per 3 oz), chicken breast, turkey, salmon, peanuts, fortified cereals.

On the forms: the clearest practical case in the whole category. Nicotinic acid binds the GPR109A receptor on skin immune cells, triggering prostaglandin release and a hot, itching flush from 30–50 mg. Niacinamide does not bind that receptor and does not flush. It also lacks nicotinic acid's lipid-modifying effects, which are a pharmacological property at gram doses rather than a nutritional one. If you want the vitamin without the flush, niacinamide is the answer. Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are sold as NAD precursors; the NIH notes they are not marketed or labelled as sources of niacin, and the FDA ruled in 2022 that NMN may not be legally marketed as a dietary supplement because it was authorised for investigation as a new drug.

Vitamin B5 (Pantothenic Acid): Coenzyme A

AI: 5 mg/day for adults. No upper limit; the NIH notes there are no reports of pantothenic acid toxicity in humans at high intakes.

Coenzyme forms: coenzyme A and the acyl carrier protein. Pantothenic acid takes its name from the Greek for "from everywhere," a fair description of both its food distribution and its metabolic reach.

Where it acts: coenzyme A is the carrier that makes acetyl-CoA — the molecule at which carbohydrate, fat and protein metabolism converge before entering the Krebs cycle. Fatty acids cannot be built or broken down without CoA. Cholesterol, steroid hormones, haem and acetylcholine all depend on it. The NIH describes CoA as "essential for fatty acid synthesis and degradation, transfer of acetyl and acyl groups, and a multitude of other anabolic and catabolic processes."

Deficiency and who is at risk: effectively never seen outside severe malnutrition and experimental settings; when induced it produces numbness and burning of the hands and feet, headache, fatigue, irritability, restlessness and disturbed sleep. The one defined risk group is people with PANK2 mutations causing pantothenate kinase-associated neurodegeneration. Food sources: beef liver (8.3 mg per 3 oz), shiitake mushrooms, sunflower seeds, chicken, avocado, yogurt, potatoes. It genuinely is everywhere.

On the forms: calcium d-pantothenate is the standard salt and the same molecule your body would extract from food. Note the "d-" — only the D-isomer is biologically active. Pantethine is further down the pathway toward CoA and has been studied at 600–900 mg/day for effects on blood lipids. That is a pharmacological dose, roughly 150 times the AI, and belongs to a different conversation.

Vitamin B6: PLP, and More Than 100 Enzymes

RDA: 1.3 mg/day for adults 19–50. UL: 100 mg/day in the US; 12 mg/day per EFSA since 2023. That gap is the subject of its own section below.

Coenzyme form: pyridoxal-5'-phosphate, abbreviated PLP or P5P. "Vitamin B6" is really six compounds — pyridoxine, pyridoxal, pyridoxamine and their phosphates — that interconvert. The NIH describes B6 as "extremely versatile, with involvement in more than 100 enzyme reactions, mostly concerned with protein metabolism."

Where it acts: PLP is the workhorse of amino acid chemistry. Every transaminase uses it, which is how amino acid carbon skeletons enter the Krebs cycle when protein is used for fuel. Glycogen phosphorylase — the enzyme that liberates glucose from stored glycogen — carries a PLP molecule in every subunit, which is a direct and often-overlooked link between B6 and blood glucose during exertion. PLP is also required for the first committed step of haem synthesis, and for the neurotransmitter pathways that make B6 and magnesium such a common pairing: the Linus Pauling Institute notes that aromatic L-amino acid decarboxylase makes serotonin from tryptophan and dopamine from L-Dopa, and that "glycine, D-serine, glutamate, histamine, and γ-aminobutyric acid (GABA), are also synthesized in reactions catalyzed by PLP-dependent enzymes."

Deficiency and who is at risk: microcytic anaemia, dermatitis with cheilosis and glossitis, EEG abnormalities, depression and confusion, weakened immune function. At risk: people with renal disease or on dialysis, people with autoimmune conditions including rheumatoid arthritis and coeliac disease, people with alcohol dependence, and people on isoniazid, which is a direct PLP antagonist. Food sources: fish, beef liver and other organ meats, potatoes and other starchy vegetables, chickpeas, and non-citrus fruit.

On the forms: pyridoxine HCl is cheap, stable and by far the most common. To become active it must be phosphorylated by pyridoxal kinase (an Mg-ATP enzyme) and then oxidised by PNPO, which is FMN-dependent. P5P skips both steps. Whether that matters in a healthy person is genuinely unresolved — but the safety question, which we come to shortly, is not merely theoretical.

P5P is the form we chose for Current, at 2 mg — a deliberately modest dose, supplied in the form that skips the PNPO conversion step described above. The safety section further down explains why the low number is a feature rather than a compromise.

Vitamin B7 (Biotin): Five Carboxylases and a Lab-Test Problem

AI: 30 mcg/day for adults. No upper limit; the NIH notes there is no evidence in humans that biotin is toxic at high intakes. That is not the same as saying high intakes are consequence-free, as you will see.

Coenzyme form: biotin itself, covalently attached to its enzymes by holocarboxylase synthetase. It acts as a carbon dioxide carrier.

Where it acts: five carboxylases. Pyruvate carboxylase converts pyruvate to oxaloacetate, replenishing the Krebs cycle and starting gluconeogenesis. Acetyl-CoA carboxylase 1 and 2 control fatty acid synthesis and the switch determining whether mitochondria burn fat. Propionyl-CoA carboxylase and methylcrotonyl-CoA carboxylase handle odd-chain fatty acids and leucine catabolism.

Deficiency and who is at risk: rare. It presents as thinning hair progressing to total body hair loss, a scaly red rash around the eyes, nose and mouth, conjunctivitis, seizures, and neurological findings including depression and lethargy. At risk: people with biotinidase deficiency (a rare recessive disorder screened for at birth in most of the US); people eating large amounts of raw egg white, which contains avidin, a glycoprotein that binds biotin so tightly it prevents absorption — cooking denatures it; people with chronic alcohol exposure; and pregnant women, at least a third of whom develop marginal deficiency. Food sources: beef liver (30.8 mcg per 3 oz), cooked whole eggs (10 mcg), salmon, sunflower seeds, sweet potato, almonds.

The dose problem: biotin is sold at 5,000 and 10,000 mcg for hair and nails — 150 to 300 times the AI, on evidence that is essentially limited to people with actual biotin deficiency or brittle nail syndrome. The FDA has issued a safety communication because high biotin intakes interfere with immunoassays, producing falsely high or falsely low results. The NIH notes that "even a single 10 mg dose of biotin has interfered with thyroid function tests administered within 24 hours." Biotin interference has caused falsely low troponin results in people being evaluated for heart attack. This is the clearest existing counterexample to "water-soluble means harmless."

Vitamin B9 (Folate): Folic Acid, 5-MTHF, Folinic Acid

RDA: 400 mcg DFE/day for adults, 600 mcg DFE in pregnancy, 500 mcg DFE in lactation. UL: 1,000 mcg/day — and this applies only to synthetic folate from supplements and fortified foods, not to folate in food.

The DFE unit exists because folic acid is better absorbed than food folate: 1 mcg DFE equals 1 mcg food folate, 0.6 mcg folic acid taken with food, or 0.5 mcg folic acid on an empty stomach. At least 85% of folic acid is bioavailable with food, against about 50% of naturally occurring folate. One honest wrinkle: "Factors for converting mcg DFE to mcg for supplemental folate in the form of 5-MTHF have not been formally established." The DFE system predates widespread 5-MTHF use.

Coenzyme forms and where they act: tetrahydrofolate and its one-carbon derivatives — 5,10-methylene-THF for thymidine synthesis, 10-formyl-THF for purines, 5-methyl-THF for the methylation cycle. Folate is the body's one-carbon delivery service, supplying the carbon for thymidine (without which DNA cannot be replicated) and the methyl group that converts homocysteine back to methionine. This is why deficiency shows up first in rapidly dividing tissue.

Deficiency and who is at risk: megaloblastic anaemia — large, abnormally nucleated red cells — plus weakness, fatigue, irritability, and in pregnancy a markedly elevated risk of neural tube defects. At risk: people with alcohol use disorder, women of childbearing age, pregnant women, people with coeliac disease or inflammatory bowel disease, people on methotrexate (a DHFR inhibitor by design), and people on certain anticonvulsants. Food sources: beef liver (215 mcg DFE per 3 oz), spinach (131 mcg per half cup cooked), asparagus, Brussels sprouts, lentils, black-eyed peas, avocado, and — in the US since 1998 — enriched grain products.

Folic acid vs 5-MTHF vs folinic acid

Folic acid is fully oxidised pteroylmonoglutamate. It does not occur meaningfully in fresh food. To be used, it must be reduced twice by dihydrofolate reductase — first to dihydrofolate, then to tetrahydrofolate — and only then can it enter the folate cycle.

5-MTHF (L-5-methyltetrahydrofolate, sold as Metafolin, Quatrefolic and similar) is the form that actually circulates in your blood. It bypasses DHFR entirely and enters the methylation cycle directly. Its one real limitation is that 5-MTHF can only exit the folate pool via methionine synthase, which requires B12. In B12 deficiency, that exit is blocked.

Folinic acid (5-formyl-THF, leucovorin) is a reduced folate that enters upstream of the methyl trap, so it can supply the whole folate pool including the DNA-synthesis branch. It is a prescription drug in oncology and a legitimate supplement form, and it is the one most people have never heard of.

The DHFR bottleneck and unmetabolized folic acid

Here is what is real and what is not.

Real: human DHFR is remarkably slow. Bailey and Ayling, publishing in PNAS in 2009, developed a sensitive assay and measured DHFR activity in human liver samples from organ donors and surgery. Their finding, verbatim: "the reduction of folic acid by DHFR per gram of human liver (n = 6)... is, on average, less than 2% of that in rat liver at physiological pH. Moreover, in contrast to rats, there was almost a 5-fold variation of DHFR activity among the human samples." They concluded that "the benefit of its use in high doses will be limited by saturation of DHFR, especially in individuals possessing lower than average activity."

Also real: unmetabolized folic acid — folic acid circulating in the blood, unreduced — is measurable in nearly all US serum samples. The NIH notes it appears after single doses of 300–400 mcg, the amount in a typical supplement, but not after 100–200 mcg.

Not established: that this causes harm. Associations have been proposed with natural killer cell function and with cognitive outcomes in older adults with low B12 status. None of it is settled. Folic acid fortification remains one of the most successful public health interventions on record, and folic acid is the only form with randomized trial evidence behind neural tube defect prevention. Six of one, honest about both: the biochemistry of the bottleneck is well documented, and the clinical consequence is unproven.

Vitamin B12: Four Cobalamins and an Absorption Ceiling

RDA: 2.4 mcg/day for adults. No upper limit — the NIH did not establish one "because of its low potential for toxicity."

Coenzyme forms and where they act: two, and only two. Methylcobalamin works in the cytosol as the cofactor for methionine synthase; its failure raises homocysteine and traps folate. Adenosylcobalamin works in the mitochondria as the cofactor for methylmalonyl-CoA mutase, which handles propionyl-CoA from odd-chain fatty acids and branched-chain amino acids; its failure raises methylmalonic acid, the more specific deficiency marker and the reason a normal serum B12 does not fully exclude deficiency. Cyanocobalamin and hydroxocobalamin are not coenzymes; they are delivery forms that get converted.

Deficiency and who is at risk: the NIH lists "megaloblastic anemia... low counts of white and red blood cells, platelets, or a combination; glossitis of the tongue; fatigue; palpitations; pale skin; dementia; weight loss; and infertility." The neurological damage — subacute combined degeneration of the spinal cord — can become irreversible. At risk: older adults (atrophic gastritis reduces the stomach acid needed to release B12 from food protein), people with pernicious anaemia, coeliac or Crohn's disease, people after gastric or ileal surgery, long-term metformin and proton pump inhibitor users, vegans and vegetarians, and infants of vegan mothers. Food sources: animal products only in nature — fish, meat, poultry, eggs, dairy — plus fortified cereals and fortified nutritional yeast.

Why the big B12 number on a label is misleading

B12 absorption has a hard ceiling, and it is low. B12 released from food binds intrinsic factor secreted by stomach parietal cells, and the complex is taken up by receptors in the distal ileum. The NIH is specific: absorption "decreases drastically when the capacity of intrinsic factor is exceeded (at 1–2 mcg of vitamin B12)." Beyond that, only passive diffusion is left, and it is inefficient — "about 2% at doses of 500 mcg and 1.3% at doses of 1,000 mcg."

Run the arithmetic on a 50 mcg dose. Intrinsic factor handles perhaps 1.5–2 mcg. Passive diffusion of the remainder at roughly 1% adds about another 0.5 mcg. Total realistically absorbed: somewhere around 2 to 2.5 mcg, which is approximately the RDA. The "2,083% Daily Value" on the label describes what went into the glass, not what crossed the gut wall. The large number exists precisely because the passive fraction is small; it is not a mistake, but it is not a superpower either.

On the forms: methylcobalamin is widely marketed as better absorbed. The NIH states the opposite of that claim as plainly as it states anything: "No evidence indicates that absorption rates of vitamin B12 in supplements vary by form of the vitamin." What is true is more modest. Cyanocobalamin carries a cyanide group that must be removed and excreted — trivial at nutritional doses, and relevant mainly in smokers, in people with kidney impairment, and in the rare condition Leber's hereditary optic neuropathy. Hydroxocobalamin has a longer half-life and is preferred for injections. Adenosylcobalamin is the mitochondrial form. If you want a form-based reason to prefer methylcobalamin, "it is one of the two coenzyme forms and avoids the cyanide group" is defensible. "It absorbs better" is not.

How the Methylation Cycle Works, in Plain Language

Methylation is the transfer of a single carbon atom with three hydrogens — a CH₃ group — from one molecule to another. It happens roughly a billion times a second across the body, and it is how a great many biological switches get flipped.

Follow the loop.

1. Homocysteine → methionine. The enzyme is methionine synthase. It needs two things at once: a methyl group donated by 5-MTHF (folate) and a methylcobalamin (B12) cofactor to carry that methyl group across. Both, or nothing.
2. Methionine → SAMe. Methionine adenosyltransferase attaches ATP to methionine to make S-adenosylmethionine, the universal methyl donor. This step costs ATP and requires magnesium.
3. SAMe donates its methyl group. To DNA (gene expression). To phosphatidylethanolamine, making phosphatidylcholine (cell membranes and myelin). To guanidinoacetate, making creatine — which consumes a large share of all methyl groups. To norepinephrine, making epinephrine. To N-acetylserotonin, making melatonin. To histones. To dozens of small molecules on their way to being excreted.
4. SAMe → SAH → homocysteine. Having given away its methyl group, SAMe becomes S-adenosylhomocysteine, which is hydrolysed back to homocysteine. The loop closes.

There is also an exit. Homocysteine can leave the cycle permanently through transsulfuration, becoming cystathionine and then cysteine — the rate-limiting input to glutathione. Both enzymes on that path, cystathionine beta-synthase and cystathionase, are PLP-dependent. So B6 does not run the methylation loop; it runs the drain.

That is the tidy summary of who does what: folate and B12 recycle homocysteine; B6 disposes of it; riboflavin supplies the FAD that lets MTHFR make 5-MTHF in the first place; magnesium powers the ATP step. Four B vitamins and a mineral, all in one loop.

One consequence deserves its own sentence. Because 5-MTHF's only exit is through methionine synthase, B12 deficiency traps the entire folate pool as 5-MTHF — the "methyl folate trap." High-dose folic acid can then correct the anaemia by mass action while the neurological damage continues unchecked. This is why the UL for synthetic folate is 1,000 mcg/day and why B12 status should be checked before anyone takes high-dose folate.

MTHFR: What the C677T Variant Actually Does

MTHFR is an enzyme: methylenetetrahydrofolate reductase. It performs one step — converting 5,10-methylene-THF into 5-methyl-THF — and that step is physiologically irreversible, which is why it matters. The C677T variant substitutes valine for alanine at position 222 (Ala222Val) and produces a thermolabile enzyme with reduced activity.

Prevalence, honestly. The NIH reports that "about 25% of Hispanics, 10% of Caucasians and Asians, and 1% of African Americans are homozygous for the 677C>T MTHFR polymorphism." The CDC puts the broader picture bluntly: more people in the United States carry one or two copies of C677T than don't. This is not a rare mutation. It is a common variant, and calling it a "mutation" is part of how it got oversold.

Correction one: MTHFR carriers can process folic acid

The single most repeated claim in methylfolate marketing — that people with MTHFR variants "can't process folic acid" — is biochemically wrong, and the error is easy to state. Reducing folic acid to tetrahydrofolate is dihydrofolate reductase's job. DHFR is a different enzyme, encoded by a different gene, on a different chromosome. MTHFR acts several steps later, on a folate that has already been reduced. A C677T variant has no bearing on whether folic acid can be reduced.

The CDC says it in one line: "People with an MTHFR gene variant can process all types of folate, including folic acid." And the size of the actual effect is small — CDC notes TT genotype individuals have blood folate levels only about 16% lower than CC individuals at equal folic acid intake, and that "your folic acid intake is more important than your MTHFR genotype for determining the amount of folate in your blood."

Correction two: no trial has shown 5-MTHF beats folic acid in TT carriers

Supplemental 5-MTHF raises plasma folate at least as effectively as folic acid — the NIH states its bioavailability is "the same as or greater than that of folic acid." That is a pharmacokinetic finding, and it is real. What does not exist is a randomized trial demonstrating that people with the TT genotype achieve better clinical outcomes on 5-MTHF than on folic acid. Not for cardiovascular events, not for depression, not for pregnancy outcomes. The claim is extrapolated from biochemistry, not measured.

Meanwhile folic acid has the one randomized outcome nobody should discard: neural tube defect prevention. The CDC's position is unambiguous — "folic acid is the only type of folate shown to help prevent neural tube defects."

The genuinely interesting angle: it's a riboflavin problem

Here is the part the marketing skips, and it is the best thing in the MTHFR literature.

The C677T variant does not primarily reduce the enzyme's catalytic ability. It reduces the enzyme's grip on its FAD cofactor — the flavin derived from riboflavin. The mutant protein loses FAD more readily and destabilises. Which means the rational intervention for a TT carrier is not more folate. It is more riboflavin, to keep the FAD bound.

And that is what the data show. The Linus Pauling Institute notes that elevated homocysteine in TT individuals "is highly responsive to lowering with riboflavin supplementation." Wilson and colleagues, in Hypertension in 2013, found that riboflavin at just 1.6 mg/day lowered blood pressure specifically in treated hypertensive adults with the 677TT genotype — an effect not seen in CC or CT carriers. A 1.6 mg dose of a cheap vitamin, working in roughly a tenth of the population and invisible in everybody else. If personalised nutrition ever earns its keep in this corner of biochemistry, that is the shape it will take, and the winning nutrient will probably be riboflavin.

Should you get tested?

The American College of Medical Genetics and Genomics addressed this directly. Hickey, Curry and Toriello, writing in Genetics in Medicine in 2013: "MTHFR polymorphism testing has minimal clinical utility and, therefore should not be ordered as a part of a routine evaluation for thrombophilia." And for people who already have a result: "Patients who are homozygous for the 'thermolabile' variant with normal plasma homocysteine can be reassured that there is currently no evidence of increased risk for venous thromboembolism or recurrent pregnancy loss related to their MTHFR status."

If you want a number that means something, measure homocysteine. It is cheap, it reflects actual function rather than genotype, and it integrates folate, B12, B6 and riboflavin status at once.

What Are the Benefits of Methylated B Vitamins?

"Methylated B vitamins" is a phrase the supplement industry uses more loosely than the chemistry allows. Strictly, only two of the B vitamins come in a genuinely methylated form: folate as 5-MTHF (L-methylfolate) and B12 as methylcobalamin. P5P, the active form of B6, is phosphorylated, not methylated. Products advertising a "fully methylated B-complex" are describing something that does not chemically exist.

What the two real ones actually buy you is the removal of a conversion step:

• 5-MTHF instead of folic acid. Folic acid must be reduced by DHFR and then processed through MTHFR before it becomes usable. 5-MTHF arrives past both gates. It also sidesteps unmetabolised folic acid, which accumulates in circulation when intake exceeds the liver’s limited capacity to reduce it.
• Methylcobalamin instead of cyanocobalamin. The practical argument is weaker than the marketing suggests — the body strips any cobalamin back to a common core and rebuilds the form it needs, so cyanocobalamin works perfectly well for most people. The honest case for methylcobalamin is that it removes a cyanide moiety, small as that is, and skips a reconversion step.

Who has a real argument for the methylated forms: people with reduced MTHFR activity, particularly the C677T homozygous variant; anyone taking methotrexate or other folate antagonists; and people who simply prefer not to rely on a conversion step working well. That is a legitimate preference, and it is the reason we chose those forms.

Where the claim gets overstated: for someone with ordinary enzyme function and adequate intake, the difference between 5-MTHF and folic acid at nutritional doses is modest, and no trial has shown methylated forms produce a benefit you would notice. The genuine advantage is reliability — the vitamin does not depend on a conversion working — rather than potency. And it is worth repeating that folate of any form can mask a B12 deficiency while nerve damage continues underneath, which is an argument for taking the two together rather than folate alone.

Did Lowering Homocysteine Actually Help Anyone?

Mostly no, and this is the section most supplement pages leave out.

Elevated homocysteine is a well-replicated risk marker for cardiovascular disease and dementia. B vitamins lower it reliably — typically by around 25%. The obvious inference was that lowering it would lower the risk. Large trials were built to test exactly that: HOPE-2, NORVIT, SEARCH, VITATOPS, WAFACS and others.

They did not deliver. The 2017 Cochrane review by Martí-Carvajal and colleagues pooled 15 randomized trials and 71,422 participants and found no significant difference between B vitamins and placebo for myocardial infarction or all-cause mortality. An earlier meta-analysis by Clarke and colleagues in Archives of Internal Medicine in 2010, covering 8 trials and 37,485 individuals, reached the same conclusion for cardiovascular events, cancer and cause-specific mortality. Homocysteine went down. Heart attacks did not.

That is the correct headline, and the correct posture is to agree with it. Homocysteine looks like a marker of something rather than a cause of it — plausibly a readout of renal function, inflammation and overall nutritional state.

Two narrow exceptions have survived scrutiny.

Stroke. Cochrane found a small but real benefit for stroke specifically. The cleanest single trial is CSPPT (Huo et al., JAMA, 2015): 20,702 adults with hypertension in China, randomized to enalapril plus 0.8 mg folic acid or enalapril alone, median 4.5 years. First stroke occurred in 2.7% versus 3.4% (hazard ratio 0.79, 95% CI 0.68–0.93, p = 0.003). Note the setting — China does not fortify grain with folic acid, and baseline folate status was low. Effects like this tend to appear in populations that were short and disappear in populations that were not.

Brain atrophy at high baseline homocysteine. The VITACOG trial (Smith et al., PLoS ONE, 2010) randomized adults with mild cognitive impairment to folic acid 0.8 mg, B12 0.5 mg and B6 20 mg daily for 24 months, with MRI-measured brain atrophy as the outcome. The treated group lost brain volume at 0.76% per year versus 1.08% in placebo (p = 0.001), a roughly 30% reduction. The subgroup finding is the striking one: in participants with baseline homocysteine above 13 µmol/L, the atrophy rate was 53% lower with treatment, while participants below 9.5 µmol/L showed no effect at all. VITACOG is a single trial with an imaging endpoint, and it has not been replicated at scale. Treat it as a hypothesis about who responds, not as a result about what B vitamins do.

Both exceptions point at the same thing, which is the recurring lesson of nutrient trials: interventions work in people who were short of something, and averaging responders together with non-responders manufactures null results.

How Much B6 Is Too Much?

This is the fastest-moving regulatory story in the whole category, and it is a genuine reason to care about dose.

High-dose pyridoxine causes sensory peripheral neuropathy — numbness, tingling and burning in the hands and feet, sometimes progressing to ataxia. The mechanism is not fully settled; the leading explanation is that excess pyridoxine competes with PLP at enzyme sites, effectively producing a functional B6 deficiency in peripheral neurons. The NIH states that "chronic administration of 1–6 g oral pyridoxine per day for 12–40 months can cause severe and progressive sensory neuropathy," and the Linus Pauling Institute notes that symptoms typically appear above 1,000 mg/day, though rarer cases have occurred lower.

Then two regulators moved.

EFSA, 2023. The European Food Safety Authority reassessed vitamin B6 and cut its tolerable upper intake level for adults from 25 mg/day to 12 mg/day. The US Institute of Medicine's UL remains 100 mg/day. That is an eightfold disagreement between two competent bodies looking at the same literature, which tells you how thin the data at intermediate doses actually are. EFSA has been criticised for leaning on a 1987 study; that criticism is fair and does not make the underlying signal go away.

Australia's TGA, 2025. The Therapeutic Goods Administration reviewed its adverse event database and found 174 reports of peripheral neuropathy and related conditions associated with vitamin B6 products as of 4 June 2025 — 131 of them, about 75%, since 1 January 2023 (36 in 2023, 41 in 2024, 54 in the first five months of 2025). The TGA's final decision, effective 1 June 2027, restricts oral B6: products above 50 mg per recommended daily dose become pharmacist-only, and products above 200 mg become prescription-only. The scheduling entry is written around vitamin B6 as a substance — pyridoxine, pyridoxal, pyridoxamine — rather than around one particular salt, so a phosphorylated form does not automatically sit outside it.

Two things follow, and the second is the honest one.

First, dose is what matters most. A B6 dose in the 1–3 mg range — near the 1.3 mg RDA, comfortably below even EFSA's conservative 12 mg — is not part of this conversation. A 50 mg or 100 mg B6 dose in a stress or PMS formula is.

Second, P5P is plausibly safer than pyridoxine, but this is not proven. The mechanistic argument is that P5P does not need to compete for pyridoxal kinase and does not accumulate as free pyridoxine. The argument is reasonable. There is no head-to-head human trial demonstrating a lower neuropathy rate, and regulators have not treated phosphorylated forms as exempt. Anyone telling you P5P is definitively safe at high doses is telling you something the evidence does not support.

Why B Vitamins Are Not Caffeine

People describe the feeling from a good mineral-and-B formula as "calm energy" and from coffee as something sharper. That difference is real, and the mechanisms are genuinely unrelated.

What caffeine actually does

Caffeine is an adenosine receptor antagonist. Adenosine accumulates in the brain across every waking hour as a by-product of ATP use, and as it binds A1 and A2A receptors it produces the subjective sensation of tiredness. This is sleep pressure. Caffeine's structure is similar enough to adenosine to occupy those receptors without activating them — work by Huang and colleagues in Nature Neuroscience in 2005 established that the arousal effect runs specifically through A2A receptors.

Three consequences follow, and they are all mechanical.

Caffeine produces no ATP. It contributes nothing to metabolism. It removes a signal.

Adenosine keeps accumulating behind the blockade. When caffeine clears — its half-life is roughly five hours, longer with some medications, shorter in smokers — the receptors are freed and meet a larger adenosine load than they would have. That is the crash. It is not a nutrient depletion. It is a backlog.

The disruption is larger than it feels. Drake and colleagues, in the Journal of Clinical Sleep Medicine in 2013, gave 12 healthy sleepers 400 mg of caffeine — about two to three cups of coffee — at 0, 3 or 6 hours before bed. Caffeine taken six hours before bedtime reduced objectively measured total sleep time by more than one hour, and the authors noted the participants were unaware of the disturbance. That last clause is the whole point. Self-report is not a reliable instrument for your own sleep, which means the fatigue you are treating with more caffeine tomorrow may have been produced by the caffeine you had today. Coffee also increases urinary losses of several minerals, which we cover in how coffee, alcohol and sweat drain your minerals.

What cofactor provision does instead

Supplying B vitamins does not touch adenosine receptors. It supplies the coenzymes that let pyruvate dehydrogenase, the Krebs cycle and the electron transport chain run. If those coenzymes were adequate already, nothing changes. If they were short, capacity is restored.

Be clear about what that does and does not mean. It is not a stimulant effect. There is no acute onset, no dose-response rush, no tolerance and no rebound — because there is no receptor being blocked. It is also not detectable in a well-fed person, which is exactly what the Markun meta-analysis found. The claim that survives is narrow: B vitamins are required for ATP production, and being short of them constrains it. That is a mechanism claim, and it is the only one the evidence supports.

The "calm" half

The calm side has its own mechanistic story, and it is mostly B6 and magnesium.

PLP is the cofactor for glutamate decarboxylase, which converts glutamate — the main excitatory neurotransmitter — into GABA, the main inhibitory one. It is also required for the decarboxylation of 5-hydroxytryptophan into serotonin, which is the precursor to melatonin. Magnesium, separately, is an antagonist at the NMDA glutamate receptor and a positive modulator at GABA-A. Two nutrients acting on the same excitatory-inhibitory balance from different directions.

The human trials are modest and worth stating precisely.

• Stough et al., Human Psychopharmacology, 2011. 60 participants, 90 days, double-blind and placebo-controlled, high-dose B-complex. After controlling for personality and work demands, the treatment groups reported "significantly lower personal strain and a reduction in confusion and depressed/dejected mood after 12 weeks." No changes in other mood or anxiety measures. Small sample; self-reported outcomes.
• Kennedy et al., Psychopharmacology, 2010. 215 healthy males, 33 days, a high-dose B-complex with vitamin C and minerals. Significant improvements on the Perceived Stress Scale (p < 0.05), the GHQ-12 (p < 0.05) and the POMS vigour subscale (p < 0.05), plus reduced mental tiredness. Note this was a combination product, so the B vitamins cannot be isolated.
• Pouteau et al., PLoS ONE, 2018. 264 healthy adults with severe stress and low magnesium status, randomized to 300 mg magnesium alone or magnesium plus 30 mg pyridoxine for 8 weeks. Both arms improved substantially. In the severe-stress subgroup, the combination produced a 3.16-point greater improvement in the Depression Anxiety Stress Scale (95% CI 0.50–5.82, p = 0.0203) — about 24% more improvement than magnesium alone. Two caveats worth keeping: the trial used pyridoxine HCl, not P5P, and a follow-up analysis by Noah and colleagues in Magnesium Research in 2020 found that B6 did not further increase erythrocyte magnesium. The synergy appears to be on stress outcomes, not on magnesium uptake.

Taken together: a real but small signal, in people who were stressed or nutritionally short, on self-reported measures. Not a sedative. Not a stimulant. If you are running on empty because of chronic stress, the relationship between burnout and mineral depletion is the more useful frame than any single nutrient.

Almost no electrolyte mix includes B vitamins at all — we tallied what eight of them actually contain in the 2026 comparison, and looked at the caffeine-and-sugar approach in Current vs Liquid I.V.

Why Magnesium and B Vitamins Belong Together

This is the best "why these two together" story in nutrition, and it is not a marketing construction.

Nearly every B vitamin has to be phosphorylated to become active, and phosphorylation is done by kinases. The substrate of a kinase is not ATP. It is Mg-ATP. Magnesium neutralises the negative charge on ATP's phosphate groups so the enzyme can position and cleave them. No magnesium, no functional ATP, no activation.

Concretely:

• Thiamine → TPP requires thiamine pyrophosphokinase, which the Linus Pauling Institute states requires magnesium and ATP explicitly.
• Pyridoxine → PLP requires pyridoxal kinase, which is Mg-ATP dependent. Several PLP-dependent enzymes then require magnesium themselves.
• Riboflavin → FMN → FAD requires riboflavin kinase and FAD synthetase, both ATP-dependent.
• Pantothenic acid → CoA begins with pantothenate kinase, ATP-dependent.
• Methionine → SAMe, the methyl donor step, is ATP-dependent.

And the dependency runs in both directions, which is the elegant part. ATP is made by the Krebs cycle and the electron transport chain, which need TPP, FAD and NAD. Those coenzymes are made by Mg-ATP-dependent kinases. Magnesium is required to make the ATP that is required to make the coenzymes that are required to make the ATP. In practice the loop is buffered and self-sustaining — but it also means that a shortfall anywhere propagates. About 48% of Americans consume less magnesium than the estimated average requirement, which makes it the likeliest weak link. We go through this properly in what magnesium actually does and in the signs you might be running low.

Magnesium is also required to activate vitamin D — the hydroxylase enzymes and the transport protein all depend on it — which is why magnesium comes first with vitamin D. Same principle, different vitamin.

What Current Actually Contains, and What It Doesn't

Now that the mechanism is on the table, here is how it shows up in a real formula — including the parts most brands would rather not itemise.

Current contains six bioactive B vitamins, not eight. There is no riboflavin and no biotin. That is a design decision with real trade-offs, and we would rather explain it than call it a "complete B-complex," which it is not.

B vitamin	Form used	Amount per stick	% Daily Value
B1 Thiamine	Thiamine HCl	5 mg	417%
B2 Riboflavin	—	Not included	—
B3 Niacin	Niacinamide	25 mg	156%
B5 Pantothenic acid	Calcium d-pantothenate	5 mg	100%
B6	Pyridoxal-5'-phosphate (P5P)	2 mg	118%
B7 Biotin	—	Not included	—
B9 Folate	5-MTHF	400 mcg DFE	100%
B12	Methylcobalamin	50 mcg	2,083%

The legitimate design point. The two conversion steps that riboflavin normally gates are already bypassed. P5P is supplied directly, so it does not need the FMN-dependent PNPO reaction. 5-MTHF is supplied directly, so it does not need MTHFR and its FAD cofactor. Riboflavin's role as an activator of other B vitamins is genuinely sidestepped by choosing the downstream forms.

The other half, honestly. Nothing in the formula substitutes for riboflavin's own direct jobs. FMN in Complex I. FAD in Complex II. The FAD-dependent acyl-CoA dehydrogenases that start fat oxidation. Glutathione reductase. Those require riboflavin itself, and a formula without it does not cover them. Riboflavin is reasonably abundant in dairy, eggs, meat, mushrooms and fortified grains, and frank deficiency is uncommon in people eating any of those — but "usually adequate from food" is a different statement from "supplied here," and we are not going to blur the two. The same goes for biotin, which is widespread in food and where the more common problem is people taking 10,000 mcg and confounding their thyroid panel.

On the niacin form: niacinamide at 25 mg, not nicotinic acid. No flushing, and 10 mg below the 35 mg UL, which is itself a flushing-based limit rather than a toxicity-based one.

On the B6 dose: 2 mg of P5P. That is 1.5 times the 1.3 mg RDA and about a sixth of EFSA's revised 12 mg limit. Given where B6 regulation is heading, a formula built around 50 or 100 mg of pyridoxine looks less clever every year.

On the B12 number: 2,083% DV is arithmetically correct and physiologically misleading, for the reasons laid out above. Realistically about 2–2.5 mcg is absorbed. We would rather be the brand that explains the ceiling than the brand that prints the percentage and hopes you are impressed by it. If you want to get better at reading these numbers generally, how to read an electrolyte label is the practical version.

On the magnesium: 220 mg from three forms — bisglycinate, malate, and ionic inland seawater. That is the mineral that activates the B vitamins in the same glass, which is the actual reason for pairing them rather than a slogan. The forms of magnesium differ too, in the same way and for the same reasons.

Where the Evidence Is Weak

Being specific about uncertainty is more useful than hedging everything equally.

• Whether bioactive forms outperform precursor forms in healthy people. Genuinely unknown. Bioavailability comparisons exist; clinical outcome comparisons largely do not. There is no trial showing P5P beats pyridoxine for any endpoint, and none showing 5-MTHF beats folic acid for any clinical outcome.
• Whether unmetabolized folic acid causes harm. Its existence is documented; its consequences are not. Proposed associations with NK cell function and with cognition in older adults with low B12 remain unresolved.
• What the right B6 upper limit is. EFSA says 12 mg. The US says 100 mg. That is an eightfold disagreement between serious bodies, which is a fair description of the underlying data quality at intermediate doses.
• Whether P5P carries less neuropathy risk than pyridoxine. Mechanistically plausible. Not demonstrated in humans. Regulators have not granted phosphorylated forms an exemption.
• Whether B vitamins do anything for mood or fatigue in replete people. The best available answer is no. Markun 2021, with 16 trials and 6,276 participants, found nothing for cognition or depression. Young 2019 found a small stress signal concentrated in people with poor baseline status. Take the null seriously.
• Whether homocysteine lowering helps anyone. Cochrane 2017, across 71,422 participants, says not for heart attack or death. Stroke shows a small benefit, mostly in unfortified populations. VITACOG's brain-atrophy result in people above 13 µmol/L is one trial with an imaging endpoint and needs replication.
• How much a formula without riboflavin gives up. Unquantified. The bypass argument for P5P and 5-MTHF is sound. The gap in Complex I, Complex II, beta-oxidation and glutathione reductase is also real. Nobody has measured the net.

Myths Worth Retiring

"A fully methylated B-complex"

Only two B vitamins have methylated forms: folate as 5-methyltetrahydrofolate and B12 as methylcobalamin. P5P is phosphorylated. TPP is pyrophosphorylated. Niacinamide is an amide. FAD is a dinucleotide. There is no such thing as methylated thiamine or methylated biotin. "Fully methylated" is a marketing phrase describing a chemical category that contains two members.

"Methylcobalamin absorbs better than cyanocobalamin"

The NIH: "No evidence indicates that absorption rates of vitamin B12 in supplements vary by form of the vitamin." Both are absorbed by the same intrinsic-factor pathway with the same ceiling. There are defensible reasons to prefer methylcobalamin — it is a coenzyme form, it avoids the cyanide group, it is relevant in smokers and kidney impairment — but absorption is not one of them.

"MTHFR carriers can't process folic acid"

Wrong enzyme. Reducing folic acid is DHFR's job. MTHFR acts several steps downstream on folate that is already reduced. The CDC: "People with an MTHFR gene variant can process all types of folate, including folic acid."

"Bright yellow urine means it's working"

Bright yellow urine is riboflavin. Riboflavin is fluorescent yellow, absorption is limited above roughly 27 mg in a single dose, and the surplus leaves in urine within hours. Flavinuria is excretion, not absorption. It tells you the dose exceeded what you could take up, which is the opposite of the inference people draw. It is harmless and it is not a signal. A formula without riboflavin will not turn urine yellow — that is a statement about riboflavin content, not about efficacy.

"Water-soluble means you can't take too much"

Three counterexamples, all documented. High-dose pyridoxine causes sensory peripheral neuropathy that can be irreversible — this is why EFSA cut its UL to 12 mg and why Australia is restricting products above 50 mg. Nicotinic acid causes flushing from 30–50 mg and, at gram doses, hepatotoxicity. Biotin at supplement doses interferes with immunoassays, including troponin tests used to diagnose heart attacks and thyroid function tests — a single 10 mg dose is enough. Water solubility affects how fast something leaves. It says nothing about what it does while it is there.

"B vitamins will keep you up at night"

There is no receptor mechanism for this. B vitamins have no stimulant pharmacology. What does exist is a plausible indirect route: B6 is required for melatonin synthesis, so timing could in principle matter at the margins. Reports of insomnia from B-complexes are common and largely anecdotal, and many B-complex products also contain caffeine or green tea extract, which is a more parsimonious explanation. If a product keeps you awake, check the full ingredient list before blaming the vitamins.

"You should take a high-dose B-complex for energy"

See the whole first section. B vitamins are catalytic, enzymes are saturable, and the meta-analytic evidence in non-deficient people is null. A dose near the RDA covers the requirement. A dose 5,000% of the RDA covers the requirement and produces expensive urine.

Frequently Asked Questions

What are the 8 B vitamins?

Thiamine (B1), riboflavin (B2), niacin (B3), pantothenic acid (B5), pyridoxine (B6), biotin (B7), folate (B9) and cobalamin (B12). The gaps in the numbering exist because B4, B8, B10 and B11 were assigned to substances that turned out not to be vitamins. The eight are chemically unrelated to each other; what they share is that each becomes a coenzyme.

Do B vitamins give you energy?

No. They contain zero calories. They are catalytic cofactors that help convert food into ATP, and they emerge from those reactions unchanged, ready to work again. Supplementation only plausibly changes how you feel if intake was inadequate to begin with — Markun and colleagues, pooling 16 trials and 6,276 participants in Nutrients in 2021, found no effect on cognition or depression in people who were not deficient.

What is the difference between methylcobalamin and cyanocobalamin?

Methylcobalamin is one of the two coenzyme forms your body actually uses; cyanocobalamin is a synthetic, highly stable form carrying a cyanide group that must be removed and excreted. That cyanide load is negligible at nutritional doses but matters in smokers and in kidney impairment. On absorption, the NIH is explicit that no evidence indicates absorption varies by form. Both go through the same intrinsic-factor pathway with the same ceiling.

Is methylfolate better than folic acid?

It raises plasma folate at least as effectively and it bypasses the slow DHFR reduction step, which is a genuine biochemical advantage. But no randomized trial has shown better clinical outcomes with 5-MTHF, including in people with MTHFR variants, and folic acid remains the only form with randomized evidence behind neural tube defect prevention. Reasonable to prefer; not established as superior.

What is P5P vitamin B6, and is it better than pyridoxine?

P5P is pyridoxal-5'-phosphate, the coenzyme form of B6. Pyridoxine HCl has to be converted into it by two enzymes — a magnesium-dependent kinase and a riboflavin-dependent oxidase. P5P skips both. Whether that translates into any measurable advantage in a healthy person is unproven. The more meaningful difference may be safety at high doses, and that too is plausible rather than demonstrated.

Can you take too much B6?

Yes, and this is the clearest safety issue among the B vitamins. High-dose pyridoxine causes sensory peripheral neuropathy that can be irreversible. EFSA cut its tolerable upper intake level from 25 mg to 12 mg per day in 2023; the US limit is still 100 mg. Australia's TGA logged 174 reports of peripheral neuropathy linked to B6 products as of June 2025, about 75% of them since January 2023, and is restricting products above 50 mg from June 2027.

Why is my pee bright yellow after taking B vitamins?

Riboflavin. It is a fluorescent yellow pigment, absorption saturates at around 27 mg in a single dose, and the excess is excreted within a few hours. It is harmless — and it is evidence of excretion, not of absorption. A supplement without riboflavin will not do it, which says nothing about whether the other B vitamins in it are working.

Should I take B vitamins in the morning or at night?

There is no established requirement either way, and no receptor mechanism by which B vitamins would act as stimulants. Morning with food is a reasonable default: several are better absorbed with a meal, and it sidesteps the question entirely. If a B-complex seems to keep you awake, check whether it also contains caffeine or green tea extract, which many do.

What are the symptoms of B vitamin deficiency?

They differ by vitamin. Cracks at the corners of the mouth and a sore, inflamed tongue point toward riboflavin or B6. Numbness and tingling in the hands and feet point toward B1, B6 or B12. Large-celled (megaloblastic) anaemia points toward folate or B12. Memory changes and gait problems point toward B12. Any of these warrants a blood test rather than a supplement — and for B12, methylmalonic acid is more sensitive than serum B12 alone.

Should I get tested for MTHFR?

The American College of Medical Genetics and Genomics recommends against routine testing, stating that MTHFR polymorphism testing has minimal clinical utility. If you want a number that reflects actual function, measure homocysteine — it integrates folate, B12, B6 and riboflavin status at once and, unlike a genotype, it can change.

Do B vitamins help with stress?

A little, in people who are stressed or nutritionally short, on self-reported measures. Young and colleagues, pooling 16 trials in Nutrients in 2019, found a small significant benefit for stress (SMD 0.23, p = 0.03), no significant effect on depressive symptoms, and none on anxiety — with benefits concentrated in participants with poor baseline status. That is a repletion effect, not a pharmacological one. Chronic stress also increases mineral losses, which is a separate and better-established piece of the same picture.

Is a daily B-complex worth taking?

It depends entirely on whether you are short. If your diet is varied and includes animal products, probably not. If you are vegan, over 60, on metformin or a proton pump inhibitor, post-bariatric surgery, drinking heavily, or eating very little, the odds shift considerably. Modest, RDA-adjacent doses in bioactive forms are a sensible way to cover the gap — which is the logic behind building a daily foundation rather than chasing megadoses.

What are the benefits of methylated B vitamins?

Only folate as 5-MTHF and B12 as methylcobalamin are genuinely methylated; P5P is phosphorylated, not methylated. Their advantage is reliability rather than potency — they arrive past a conversion step, which matters most for people with reduced MTHFR activity. For someone with ordinary enzyme function, no trial has shown a difference you would notice.

Sources

1. NIH Office of Dietary Supplements. "Thiamin — Health Professional Fact Sheet." ods.od.nih.gov
2. NIH Office of Dietary Supplements. "Riboflavin — Health Professional Fact Sheet." ods.od.nih.gov
3. NIH Office of Dietary Supplements. "Niacin — Health Professional Fact Sheet." ods.od.nih.gov
4. NIH Office of Dietary Supplements. "Pantothenic Acid — Health Professional Fact Sheet." ods.od.nih.gov
5. NIH Office of Dietary Supplements. "Vitamin B6 — Health Professional Fact Sheet." ods.od.nih.gov
6. NIH Office of Dietary Supplements. "Biotin — Health Professional Fact Sheet." ods.od.nih.gov
7. NIH Office of Dietary Supplements. "Folate — Health Professional Fact Sheet." ods.od.nih.gov
8. NIH Office of Dietary Supplements. "Vitamin B12 — Health Professional Fact Sheet." ods.od.nih.gov
9. NIH Office of Dietary Supplements. "Magnesium — Health Professional Fact Sheet." ods.od.nih.gov
10. Linus Pauling Institute, Oregon State University. "Thiamin." lpi.oregonstate.edu
11. Linus Pauling Institute, Oregon State University. "Vitamin B6." lpi.oregonstate.edu
12. Linus Pauling Institute, Oregon State University. "Folate." lpi.oregonstate.edu
13. Markun S, Gravestock I, Jäger L, Rosemann T, Pichierri G, Burgstaller JM. "Effects of Vitamin B12 Supplementation on Cognitive Function, Depressive Symptoms, and Fatigue: A Systematic Review, Meta-Analysis, and Meta-Regression." Nutrients, 2021;13(3):923. doi:10.3390/nu13030923
14. Young LM, Pipingas A, White DJ, Gauci S, Scholey A. "A Systematic Review and Meta-Analysis of B Vitamin Supplementation on Depressive Symptoms, Anxiety, and Stress: Effects on Healthy and 'At-Risk' Individuals." Nutrients, 2019;11(9):2232. mdpi.com
15. Martí-Carvajal AJ, Solà I, Lathyris D, Dayer M. "Homocysteine-lowering interventions for preventing cardiovascular events." Cochrane Database of Systematic Reviews, 2017. cochranelibrary.com
16. Clarke R, Halsey J, Lewington S, et al. "Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37,485 individuals." Archives of Internal Medicine, 2010;170(18):1622–1631. PubMed
17. Huo Y, Li J, Qin X, et al. "Efficacy of Folic Acid Therapy in Primary Prevention of Stroke Among Adults With Hypertension in China: The CSPPT Randomized Clinical Trial." JAMA, 2015;313(13):1325–1335. jamanetwork.com
18. Smith AD, Smith SM, de Jager CA, et al. "Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial." PLoS ONE, 2010;5(9):e12244. journals.plos.org
19. Bailey SW, Ayling JE. "The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake." PNAS, 2009;106(36):15424–15429. pnas.org
20. Pfeiffer CM, Sternberg MR, Fazili Z, et al. "Unmetabolized folic acid is detected in nearly all serum samples from US children, adolescents, and adults." Journal of Nutrition, 2015. PubMed
21. Hickey SE, Curry CJ, Toriello HV. "ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing." Genetics in Medicine, 2013;15(2):153–156. nature.com
22. Centers for Disease Control and Prevention. "MTHFR Gene Variant and Folic Acid Facts." cdc.gov
23. Wilson CP, McNulty H, Ward M, et al. "Blood Pressure in Treated Hypertensive Individuals With the MTHFR 677TT Genotype Is Responsive to Intervention With Riboflavin." Hypertension, 2013;61(6):1302–1308. ahajournals.org
24. EFSA Panel on Nutrition, Novel Foods and Food Allergens. "Scientific opinion on the tolerable upper intake level for vitamin B6." EFSA Journal, 2023;21(5):8006. efsa.onlinelibrary.wiley.com
25. Therapeutic Goods Administration (Australia). "Stronger safety controls to be introduced for products containing vitamin B6." tga.gov.au
26. Therapeutic Goods Administration (Australia). "Health supplements containing vitamin B6 can cause peripheral neuropathy." tga.gov.au
27. Drake C, Roehrs T, Shambroom J, Roth T. "Caffeine Effects on Sleep Taken 0, 3, or 6 Hours before Going to Bed." Journal of Clinical Sleep Medicine, 2013;9(11):1195–1200. jcsm.aasm.org
28. Huang ZL, Qu WM, Eguchi N, et al. "Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine." Nature Neuroscience, 2005;8(7):858–859. nature.com
29. Reichert CF, Deboer T, Landolt HP. "Adenosine, caffeine, and sleep–wake regulation: state of the science and perspectives." Journal of Sleep Research, 2022. PMC
30. Stough C, Scholey A, Lloyd J, Spong J, Myers S, Downey LA. "The effect of 90 day administration of a high dose vitamin B-complex on work stress." Human Psychopharmacology, 2011;26(7):470–476. onlinelibrary.wiley.com
31. Kennedy DO, Veasey R, Watson A, et al. "Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males." Psychopharmacology, 2010;211(1):55–68. link.springer.com
32. Pouteau E, Kabir-Ahmadi M, Noah L, et al. "Superiority of magnesium and vitamin B6 over magnesium alone on severe stress in healthy adults with low magnesemia: A randomized, single-blind clinical trial." PLoS ONE, 2018;13(12):e0208454. journals.plos.org
33. Noah L, Pickering G, Mazur A, et al. "Impact of magnesium supplementation, in combination with vitamin B6, on stress and magnesium status: secondary data from a randomized controlled trial." Magnesium Research, 2020;33(3):45–57. PubMed
34. US Food and Drug Administration. "Biotin Interference with Troponin Lab Tests — Assays Subject to Biotin Interference." fda.gov

Life's better mineralized.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for educational purposes and is not medical advice. Talk to your doctor before starting any supplement, especially if you are pregnant, nursing, have kidney disease, or take prescription medication.